89464-29-9Relevant academic research and scientific papers
AZAINDAZOLE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS
-
Page/Page column 189, (2010/04/27)
Disclosed are compounds of the formula (I), useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of CCR1 including autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. Also disclosed are methods of making and methods of using same.
